Oligonucleotide compounds for treatment of preeclampsia and other angiogenic disorders
US9862952B2 · kind B2 · utility
18Cited by
23References
40Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 1, 2016 |
| Grant date | Jan 9, 2018 |
| Priority date | — |
| Expiry date | Apr 1, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/50
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This disclosure relates to novel targets for angiogenic disorders. Novel oligonucleotides are also provided. Methods of using the novel oligonucleotides for the treatment of angiogenic disorders (e.g., preeclampsia) are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.